Overview
cGMP Consulting helps pharmaceutical and biotech companies comply with current Good Manufacturing Practices (cGMP) and Title 21 CFR, offering engineering and quality assurance support. It works by performing gap analyses, then designing and implementing solutions for processes, documentation, validation, and technology adoption across international manufacturing sites. The company differentiates itself through hands-on, end-to-end support that combines technical engineering and QA expertise with practical implementation at multiple regulated sites. Its goal is to enable compliant, efficient global pharmaceutical manufacturing by helping clients adopt new technologies while meeting regulatory expectations.
Work here?Claim your company
Simplify's take
What believers are saying
- October 2026 career pages show hiring for nine specialized roles across Illinois and Ohio.
- Recent August 2026 publications suggest active lead generation around FDA audit readiness.
- New service and 2026 thought leadership support cross-sell into validation, engineering, and regulatory work.
What critics are saying
- The firm discloses no funding, leaving growth dependent on client billings and staffing.
- Open roles in October 2026 signal acute utilization pressure and delivery-heavy operations.
- If anchors like AbbVie or Fresenius Kabi reduce spend, revenue concentration turns existential quickly.
What makes cGMP Consulting unique
- Since 2001, cGMP Consulting serves FDA-regulated manufacturers with compliance and technology implementation.
- It added ISO/IEC 17020:2012 accredited GMP certification audits in June 2024.
- Its 2026 content spans audit readiness, CSV, CAPA, and facility design.
Help us improve and share your feedback! Did you find this helpful?